Psychedelic Stocks Soar as Trump Signs Order to Ease Access
A container of Psilocybe mushrooms, left, alongside the final product in pill form.
Photographer: James MacDonald/BloombergShares of companies involved in psychedelic-tied therapies are surging in Monday trading after President Donald Trump signed an executive order to expedite research and access.
US-traded shares of Compass Pathways Plc spiked as much as 53% while AtaiBeckley Inc. surged by 37%. GH Research PLC jumped 34% and Definium Therapeutics, Inc. rallied 16%. The AdvisorShares Psychedelics ETF (PSIL) also climbed as much as 20% — touching its highest intraday level since July 2023.